Clinical Trial

IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Name: IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia — clinical trial record (NCT07585071)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection (In Vivo CAR-T) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia

Trial Details

NCT Number	NCT07585071
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Autoimmune Hemolytic Anemia, Relapsed/Refractory
Enrollment	18 participants
Start Date	2026-06-15
Primary Completion	2026-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-13